INS and metabolic syndrome: Our results indicated that at the age of 24 weeks, MSG-IO mice showed apparent metabolic syndrome appearances; increased body weight, body weight gain, waist circumference, and LEE index; and significant increases in fasting blood glucose and serum insulin levels and HOMA-IR index.